AI Analysis: Veterinarian–Pharmacist Collaboration

According to the PLoS One scoping review (Kambayashi et al., published July 31, 2026), pharmacist contributions to veterinary teams are growing but unevenly documented and focused mainly on compounding and dispensing (PLoS One).

• The PLoS One review retrieved 239 records and included 16 studies in the final synthesis, with the final search completed on August 30, 2025, and the article published on July 31, 2026.
• The PLoS One review found compounding and dispensing described in 10 of 16 studies (62.5%) and drug information/consultation in 6 of 16 studies (37.5%).
• The PLoS One review showed geographic clustering: the United States produced 7 of the 16 studies, New Zealand 3, and Japan 3, with publications spanning 2007 to 2024.
• Kambayashi et al., PLoS One (2026) conclude that "pharmacists are expanding their role in veterinary medicine, evolving from traditional dispensing functions to active contributors to clinical care and medication safety."

The PLoS One scoping review mapped the literature on veterinarian–pharmacist collaboration to identify roles, practices, and perceptions.

According to Kambayashi et al., PLoS One (published July 31, 2026), two reviewers searched PubMed, Web of Science, the Cochrane Library, Ichushi-Web, and Google Scholar from database inception to August 30, 2025, to identify English- and Japanese-language reports.

According to Kambayashi et al., PLoS One (2026), the authors screened 239 retrieved records, removed 58 duplicates, screened 181 records, and ultimately included 16 studies published between 2007 and 2024.

According to Kambayashi et al., PLoS One (2026), most included studies used cross-sectional survey designs and reported pharmacist roles across community pharmacies, veterinary hospitals, zoos, and academic networks.

Qualitative researchers should treat the PLoS One review (Kambayashi et al., 2026) as a baseline and design next-phase studies to produce transferable models.

According to Kambayashi et al., PLoS One (2026), the existing literature is dominated by perception-based cross-sectional surveys, so researchers should plan longitudinal or mixed-methods designs that operationalize measurable outcomes such as medication errors or adherence.

According to Kambayashi et al., PLoS One (2026), language barriers hide relevant models in non-English sources (for example, three Japanese studies were included), so qualitative teams should include cross-lingual search strategies and translation workflows to avoid Anglophone bias.

According to Kambayashi et al., PLoS One (2026), concerns about pharmacists' species-specific knowledge are a recurrent barrier, so qualitative studies should sample both professions and include observational or document-based data to triangulate perceptions with real-world practice.

Kambayashi et al., PLoS One (published July 31, 2026) document a growing but uneven role for pharmacists in veterinary medicine and call for stronger, more diverse evidence to support integrated practice.

According to Kambayashi et al., PLoS One (2026), addressing the knowledge gap in species-specific pharmacology and expanding translational education are immediate priorities for enabling deeper collaboration.

If your research team needs to synthesize survey responses, interviews, and non-English documents to design interprofessional pilots, Evidano can accelerate thematic analysis, cross-segment comparisons, and visualization for stakeholders; start by exploring Evidano Features.

Try Evidano for free to convert qualitative insights into reproducible evidence and operational recommendations: Try Evidano for free.